{{Rsnum
|rsid=1553091
|Chromosome=3
|position=187999098
|Orientation=plus
|GMAF=0.2879
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.5 | 44.6 | 16.9
| HCB | 28.9 | 40.0 | 31.1
| JPT | 34.1 | 43.2 | 22.7
| YRI | 77.8 | 20.6 | 1.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 28.9 | 40.0 | 31.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=7E-6
  |OR=1.48
  |ORtxt=[1.053-2.08]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}